Search for: "Smith v. Wyeth Pharmaceuticals Inc" Results 61 - 80 of 91
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2015, 12:56 pm
Wyeth Laboratories, Inc., 734 A.2d 1245 (N.J. 1999) – the decision that makes New Jersey the only state to adopt a direct-to-consumer (“DTC”) exception to the learned intermediary rule (putting aside West Virginia’s use of DTC as an excuse for rejecting the rule altogether). [read post]
9 Apr 2015, 5:00 am
  Two other state supreme courts have reaffirmed the learned intermediary rule since then, Wyeth, Inc. v. [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
17 Sep 2009, 4:30 am
Given the size of the overdose, no alleged illegibility of the little lines on the cup could possibly have made the slightest difference in the result.What's going on in those cases is the same thing we've already commented about in the context of the big preemption cases, Wyeth v. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]